GeneTex

  • Country / Location Selection

United States (US)

IRF6 blocking peptide

Cat. No. GTX10925-PEP

Species

 Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX10925.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-TPSMQLPPALPPQ

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Interferon Regulatory Factor 6 , Lps , Ofc6 , Pit , Pps , Pps1 , Vws , Vws1 , Irf6

Background

This gene encodes a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. The encoded protein may be a transcriptional activator. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. Mutations in this gene are also associated with non-syndromic orofacial cleft type 6. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2011]

Research Area

REFERENCE

There are currently no references for IRF6 blocking peptide (GTX10925-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for IRF6 blocking peptide (GTX10925-PEP). Be the first to share your experience with this product.
Submit a Review
Package List Price ($)
$ 239